Intelligent Photonics

Invuity’s patented Intelligent Photonics™ devices provide direct visualization of the surgical cavity enabling enhanced precision, efficiency and safety. Our technology is integrated into sophisticated retractor systems, handheld devices and intracavity drop-in illuminators; each utilizing our proprietary waveguide technology that directs and shapes light into broad, uniform illumination to provide enhanced direct visualization inside dark surgical cavities. In addition, it converts traditional thermally hot, concentrated light output to thermally cool volumetric illumination throughout the entire surgical cavity.

Find out more about our technology

Surgeon Testimonials

waveguide-home

Transforming Minimal access Surgeries Through Advanced Visualization

Invuity is committed to leveraging advanced photonics technology to transform and create a new standard of care for minimal access surgery.

precision-efficiency-safety

Invuity Announces Closing of Public Offering of Common Stock and Underwriters’ Full Exercise of Option to Purchase Additional Shares

SAN FRANCISCO, Aug. 02, 2016 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY) ("Invuity" or the "Company"), a leading surgical photonics company, today announced the closing of its public offering of 3,220,000 shares of its common stock at a price to the public of $10.00 per share, which includes the exercise in full by the underwriters of their option to purchase an additional 420,000 additional shares of common stock. The total net proceeds from the offering are estimated to be approximately $29.9 million, after deducting underwriting discounts and commissions and estimated offering expenses payable by Invuity. Piper Jaffray & Co. and Leerink Partners LLC acted as joint book-running...

Read More

Invuity Announces Pricing of Public Offering of Common Stock

SAN FRANCISCO, July 28, 2016 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY) ("Invuity" or the "Company"), a leading surgical photonics company, today announced the pricing of its public offering of 2.8 million shares of its common stock at a price to the public of $10.00 per share. In addition, the Company has granted the underwriters a 30-day option to purchase up to 420,000 additional shares of its common stock. Piper Jaffray & Co. and Leerink Partners LLC are acting as joint book-running managers for the offering. William Blair & Company, L.L.C. is acting as a co-manager for the offering. The offering is being made pursuant to an effective shelf registration statement on For...

Read More

Invuity Announces Proposed Public Offering of Common Stock

SAN FRANCISCO, July 27, 2016 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY) ("Invuity" or the "Company"), a leading surgical photonics company, today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering. Invuity expects to grant the underwriters a 30-day option to purchase additional shares of its common stock. Invuity intends to use the net proceeds from the offering for continued expansion of its sales and marketing activities, investments in research and development, potential acquisitions or investments in complementary products, technologies or businesses, and working capital and other gen...

Read More

icon-surgeon

Surgeons

Read More

icon-hospital

Hospitals & Surgery Centers

Read More

icon-patient

Patients

Read More

Testimonials

“Invuity’s Intelligent Photonics Technology is a must-have for all my surgical procedures, particularly lumpectomies, and skin and nipple sparing mastectomies. This technology enables me to make a single inframammary incision and clearly visualize deep into the surgical cavity all the way to the axilla. Additionally, it has enabled me to operate proficiently, improving the viability of the breast flap. I have reduced my surgical times while improving patient safety and aesthetic outcomes.”

Beth DuPree, MD FACS
Adjunct Assistant Professor of Surgery University of Pennsylvania
Director, Comprehensive Breast Care Surgeons
Medical Director, Breast Health Program
Holy Redeemer Health System

“The Invuity Eika illuminated minimally invasive thyroid and parathyroid self-retracting technology has revolutionized our field of endocrine surgery.  It allows for smaller incisions while improving surgical efficiency and safety.  It provides superior visualization of vital structures, and has reduced operating times, improved patient outcomes, and decreased overall costs of the procedure.  I would not do a case without this technology.”

James K. Bredenkamp, MD, FACS
Head & Neck Associates of Orange County
Chief of Surgery, Mission Regional and Trauma Med Ctr.
Director, St. Joseph and Hoag Head & Neck Oncology & Endocrine Center

“Invuity’s technology enables me to perform advanced breast procedures with remarkable visualization. This is truly an enabling technology that will be greatly appreciated by dedicated breast surgeons and plastic surgeons.”

Stephen DeSantis, MD
Chairman, Department of Surgery
Mission Hospital
Mission Viejo, CA